ES2128358T3 - Vacuna que comprende una subunidad de receptor de transferrina humana aislada de neisseria meningitidis. - Google Patents

Vacuna que comprende una subunidad de receptor de transferrina humana aislada de neisseria meningitidis.

Info

Publication number
ES2128358T3
ES2128358T3 ES92921587T ES92921587T ES2128358T3 ES 2128358 T3 ES2128358 T3 ES 2128358T3 ES 92921587 T ES92921587 T ES 92921587T ES 92921587 T ES92921587 T ES 92921587T ES 2128358 T3 ES2128358 T3 ES 2128358T3
Authority
ES
Spain
Prior art keywords
neisseria meningitidis
isolated human
vaccine including
subunit
transferrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92921587T
Other languages
English (en)
Inventor
Marie-Jose Quentin-Millet
Ling Lissolo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Pasteur Merieux Serum et Vaccines SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serum et Vaccines SA filed Critical Pasteur Merieux Serum et Vaccines SA
Application granted granted Critical
Publication of ES2128358T3 publication Critical patent/ES2128358T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/871—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA SUBUNIDAD DE MENOR PESO MOLECULAR DEL RECEPTOR DE LA TRANSFERRINA HUMANA DE UNA CEPA DE N.MENINGITIDIS, EN FORMA PURIFICADA ASI COMO UNA COMPOSICION FARMACEUTICA DE VACUNA DESTINADA A LA PREVENCION O A LA ATENUACION DE LOS EFECTOS DE UNA INFECCION DE N.MENINGITIDIS QUE CONTIENE DICHA SUBUNIDAD EN FORMA PURIFICADA.
ES92921587T 1991-10-03 1992-09-29 Vacuna que comprende una subunidad de receptor de transferrina humana aislada de neisseria meningitidis. Expired - Lifetime ES2128358T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9112176A FR2682114B1 (fr) 1991-10-03 1991-10-03 Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.

Publications (1)

Publication Number Publication Date
ES2128358T3 true ES2128358T3 (es) 1999-05-16

Family

ID=9417548

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92921587T Expired - Lifetime ES2128358T3 (es) 1991-10-03 1992-09-29 Vacuna que comprende una subunidad de receptor de transferrina humana aislada de neisseria meningitidis.

Country Status (15)

Country Link
US (2) US5618540A (es)
EP (1) EP0560969B1 (es)
JP (1) JPH06503364A (es)
AT (1) ATE174930T1 (es)
AU (1) AU668522B2 (es)
CA (1) CA2096411A1 (es)
DE (1) DE69227984T2 (es)
DK (1) DK0560969T3 (es)
ES (1) ES2128358T3 (es)
FI (1) FI107262B (es)
FR (1) FR2682114B1 (es)
GR (1) GR3029580T3 (es)
HU (1) HU219762B (es)
NO (1) NO309865B1 (es)
WO (1) WO1993007172A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
DE69418699T2 (de) * 1993-01-11 1999-09-30 Dana-Farber Cancer Institute, Boston Induktion der antworten zytotoxischer t-lymphozyten
ES2270420T3 (es) * 1993-11-08 2007-04-01 Sanofi Pasteur Limited Genes receptores de la transferrina de haemophilus.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
WO2000042193A1 (en) * 1999-01-15 2000-07-20 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigen
WO2010130898A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
WO2011024072A2 (en) * 2009-08-27 2011-03-03 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
CA2931685C (en) 2013-12-02 2021-09-07 Anthony B. Schryvers Immunogenic compositions and vaccines derived from bacterial surface receptor proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
DE69133334T2 (de) * 1990-08-23 2004-05-13 University Of North Carolina At Chapel Hill Transferrin bindende proteine aus neisseria-gonorrhoeae und neisseria-meningitidis
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.

Also Published As

Publication number Publication date
FR2682114B1 (fr) 1996-02-23
EP0560969A1 (fr) 1993-09-22
FI932490L (fi) 1993-06-01
CA2096411A1 (en) 1993-04-04
NO309865B1 (no) 2001-04-09
HUT69929A (en) 1995-09-28
US5618540A (en) 1997-04-08
WO1993007172A1 (fr) 1993-04-15
NO932009L (no) 1993-07-20
FI107262B (fi) 2001-06-29
NO932009D0 (no) 1993-06-02
AU668522B2 (en) 1996-05-09
HU9301631D0 (en) 1993-10-28
GR3029580T3 (en) 1999-06-30
FI932490A0 (fi) 1993-06-01
US5928650A (en) 1999-07-27
DE69227984T2 (de) 1999-05-12
ATE174930T1 (de) 1999-01-15
AU2764092A (en) 1993-05-03
DK0560969T3 (da) 1999-08-23
HU219762B (hu) 2001-07-30
JPH06503364A (ja) 1994-04-14
DE69227984D1 (de) 1999-02-04
FR2682114A1 (fr) 1993-04-09
EP0560969B1 (fr) 1998-12-23

Similar Documents

Publication Publication Date Title
ES2090696T3 (es) Vacunas contra infecciones de neisseria meningitidis.
MX2022010008A (es) Composiciones inmunogenicas de coronavirus y usos de las mismas.
ES2096639T3 (es) Derivados de benzofurano, benzotiofeno, indol o indolizina, su procedimiento de preparacion, asi como las composiciones que los contienen.
ES2153964T3 (es) Liberacion controlada de farmacos administrados por via sublingual o bucal.
ES2059491T3 (es) Derivados de indol con anillos condensados.
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
GT199700089A (es) Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido.
DE69131014D1 (de) Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe
CY1111341T1 (el) Πολυπεπτιδιου-εμβολια για ευρεια προστασια εναντι υπερ-λοιμογονων μηνιγγιοκοκκικων γενεαλογικων σειρων
ES2192582T3 (es) Composicion de vaccineo, conteniendo quitina, parcialmente deacetilado.
ES2092696T3 (es) Metodos y composiciones relacionadas con antigenos utiles de moraxella catarrhalis.
CY1111325T1 (el) Πολυεπιτοπικη πρωτεϊνη-φορεας
CO5640082A2 (es) Compuestos derivados de succinimida heterociclicos fusionados que son moduladores de la funcion del receptor de la hormona nuclear y composiciones farmaceuticas que los contienen
BR0113822A (pt) Vacina
PA8556801A1 (es) Compuestos de imidazopiridin como moduladores de receptor 5-ht 4
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
DE69122266D1 (de) Antivirale verbindungen
DK0560969T3 (da) Vaccine omfattende en sub-unit af human transferrinreceptoren fra Neisseria meningitidis
ES2169257T3 (es) Nuevas isoquinolinas fusionadas como ligandos del receptor de la dopamina.
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
ATE248601T1 (de) Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
DOP2025000284A (es) Compuestos y formulaciones adyuvantes útiles en vacunas neumocócicas
ES2170177T3 (es) Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 560969

Country of ref document: ES